Guillermo Lahera Forteza-rekin lankidetzan egindako argitalpenak (19)

2023

  1. A Review: Integrative Perspectives on the Features and Clinical Management of Psychotic Episodes in Pregnancy

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  2. Assessment of Tissue Expression of the Oxytocin–Vasopressin Pathway in the Placenta of Women with a First-Episode Psychosis during Pregnancy

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  3. Current Opinions about the Use of Duloxetine: Results from a Survey Aimed at Psychiatrists

    Brain Sciences, Vol. 13, Núm. 2

  4. Evidence of Increased Oxidative Stress in the Placental Tissue of Women Who Suffered an Episode of Psychosis during Pregnancy

    Antioxidants, Vol. 12, Núm. 1

  5. Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities

    Molecular Psychiatry, Vol. 28, Núm. 7, pp. 2645-2673

  6. The Placentas of Women Who Suffer an Episode of Psychosis during Pregnancy Have Increased Lipid Peroxidation with Evidence of Ferroptosis

    Biomolecules, Vol. 13, Núm. 1

  7. Women with psychotic episodes during pregnancy show increased markers of placental damage with Tenney-Parker changes

    Histology and Histopathology, Vol. 38, Núm. 10, pp. 1109-1118

2022

  1. An Updated View of the Importance of Vesicular Trafficking and Transport and Their Role in Immune-Mediated Diseases: Potential Therapeutic Interventions

    Membranes, Vol. 12, Núm. 6

  2. Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder

    Nutrients, Vol. 14, Núm. 15

  3. Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): A potential biomarker

    Journal of International Medical Research, Vol. 50, Núm. 5

  4. Gut Microbiota Metabolites in Major Depressive Disorder—Deep Insights into Their Pathophysiological Role and Potential Translational Applications

    Metabolites, Vol. 12, Núm. 1

  5. Immune-Mediated Diseases from the Point of View of Psychoneuroimmunoendocrinology

    Biology, Vol. 11, Núm. 7

  6. Nutrition, Epigenetics, and Major Depressive Disorder: Understanding the Connection

    Frontiers in Nutrition, Vol. 9

  7. The Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective

    Nutrients, Vol. 14, Núm. 5

  8. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine

    Frontiers in Oncology, Vol. 12

2021

  1. Exploring the role of nutraceuticals in major depressive disorder (MDD): Rationale, state of the art and future prospects

    Pharmaceuticals, Vol. 14, Núm. 8

  2. Micrornas as critical biomarkers of major depressive disorder: A comprehensive perspective

    Biomedicines, Vol. 9, Núm. 11

  3. Nutritional components in western diet versus mediterranean diet at the gut microbiota-immune system interplay. implications for health and disease

    Nutrients, Vol. 13, Núm. 2, pp. 1-53

  4. Physical activity as an imperative support in breast cancer management

    Cancers, Vol. 13, Núm. 1, pp. 1-30